[Plasma digoxin during treatment with "new" Lanoxin]. 1973

D Falch, and A Teien, and A E Odegaard

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001145 Arrhythmias, Cardiac Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction. Arrhythmia,Arrythmia,Cardiac Arrhythmia,Cardiac Arrhythmias,Cardiac Dysrhythmia,Arrhythmia, Cardiac,Dysrhythmia, Cardiac
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

D Falch, and A Teien, and A E Odegaard
September 1972, Lancet (London, England),
D Falch, and A Teien, and A E Odegaard
June 1975, European journal of clinical pharmacology,
D Falch, and A Teien, and A E Odegaard
August 1973, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
D Falch, and A Teien, and A E Odegaard
November 1973, British medical journal,
D Falch, and A Teien, and A E Odegaard
November 1972, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
D Falch, and A Teien, and A E Odegaard
July 1988, Arzneimittel-Forschung,
D Falch, and A Teien, and A E Odegaard
January 1974, British heart journal,
D Falch, and A Teien, and A E Odegaard
June 1991, Journal of clinical pharmacology,
D Falch, and A Teien, and A E Odegaard
January 1977, Verhandlungen der Deutschen Gesellschaft fur Kreislaufforschung,
D Falch, and A Teien, and A E Odegaard
April 1990, DICP : the annals of pharmacotherapy,
Copied contents to your clipboard!